Search Results - "Hezzell, M.J."

Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT‐proBNP Measurements by Hezzell, M.J., Rush, J.E., Humm, K., Rozanski, E.A., Sargent, J., Connolly, D.J., Boswood, A., Oyama, M.A.

“…BACKGROUND: Pleural effusion is a common cause of dyspnea in cats. N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) measurement, using a first‐generation…”
Get full text

Longitudinal Electrocardiographic Evaluation of Dogs with Degenerative Mitral Valve Disease by López‐Alvarez, J, Boswood, A, Moonarmart, W, Hezzell, M.J, Lotter, N, Elliott, J

“…BACKGROUND: Increased heart rate (HR) and decreased heart rate variability (HRV) are evident in some dogs with degenerative mitral valve disease (DMVD)…”
Get full text

Inspiratory muscle training for the treatment of dynamic upper airway collapse in racehorses: A preliminary investigation by Fitzharris, L.E., Franklin, S.H., McConnell, A.K., Hezzell, M.J., Allen, K.J.

“…•Inspiratory muscle training is used to train the respiratory muscles in isolation.•Inspiratory muscle training can be applied to racehorses in…”
Get full text

Is treatment with pimobendan associated with an increased risk of arrhythmias in dogs with heart disease? by Hillyer, S., Hezzell, M., Place, E.

“…Clinical scenario Pimobendan is a positive inotrope and balanced vasodilator via its actions as a calcium sensitiser and phosphodiesterase III inhibitor,…”
Get full text

The Combined Prognostic Potential of Serum High‐Sensitivity Cardiac Troponin I and N‐Terminal pro‐B‐Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease by Hezzell, M.J., Boswood, A., Chang, Y.‐M., Moonarmart, W., Souttar, K., Elliott, J.

“…Background Identification of factors associated with decreased survival in dogs with degenerative mitral valve disease (DMVD) will allow more accurate…”
Get full text

Transvalvular pulmonic stent angioplasty: procedural outcomes and complications in 15 dogs with pulmonic stenosis by Borgeat, K., Gomart, S., Kilkenny, E., Chanoit, G., Hezzell, M.J., Payne, J.R.

“…Balloon valvuloplasty is the treatment of choice for dogs with severe type A pulmonic stenosis (PS), but less successful for dogs with annular hypoplasia and…”
Get full text

Measurements of echocardiographic indices and biomarkers of kidney injury in dogs with chronic kidney disease by Hezzell, M.J., Foster, J.D., Oyama, M.A., Buch, J., Farace, G., Quinn, J.J., Yerramilli, M.

“…•Cardiovascular dysfunction secondary to chronic kidney disease (CKD) is a leading cause of death in human CKD patients.•CKD is common in veterinary patients,…”
Get full text

Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT ‐pro BNP Measurements by Hezzell, M.J., Rush, J.E., Humm, K., Rozanski, E.A., Sargent, J., Connolly, D.J., Boswood, A., Oyama, M.A.

“…Background Pleural effusion is a common cause of dyspnea in cats. N‐terminal pro‐B‐type natriuretic peptide ( NT ‐pro BNP ) measurement, using a…”
Get full text

Clinical Severity Score System in Dogs with Degenerative Mitral Valve Disease by López‐Alvarez, J., Elliott, J., Pfeiffer, D., Chang, Y.‐M., Mattin, M., Moonarmart, W., Hezzell, M.J., Boswood, A.

“…Background Several risk factors already have been determined for dogs with degenerative mitral valve disease (DMVD). Risk factors often have been considered in…”
Get full text

Relationship of Plasma N‐terminal Pro‐brain Natriuretic Peptide Concentrations to Heart Failure Classification and Cause of Respiratory Distress in Dogs Using a 2nd Generation ELISA Assay by Fox, P.R., Oyama, M.A., Hezzell, M.J., Rush, J.E., Nguyenba, T.P., DeFrancesco, T.C., Lehmkuhl, L.B., Kellihan, H.B., Bulmer, B., Gordon, S.G., Cunningham, S.M., MacGregor, J., Stepien, R.L., Lefbom, B., Adin, D., Lamb, K.

“…Background Cardiac biomarkers provide objective data that augments clinical assessment of heart disease (HD). Hypothesis/Objectives Determine the utility of…”
Get full text

Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone—a pilot study by Hezzell, M.J., Boswood, A., López-Alvarez, J., Lötter, N., Elliott, J.

“…Spironolactone improves outcome in dogs with advanced myxomatous mitral valve disease (MMVD). Its efficacy in preclinical MMVD is unknown. The hypothesis was…”
Get full text

Anodal stimulation in two dogs with transvenous permanent bipolar pacemakers by Oyama, M.A., Hezzell, M.J., Laughlin, D.S., Thorn, C.L., Kraus, M.S., Gelzer, A.R.

“…Management of symptomatic bradyarrhythmias such as complete atrioventricular block often involves permanent implantation of a transvenous pacemaker. Both…”
Get full text